Abstract
The United States Food and Drug Administration currently states that the use of stimulants in patients with tic disorders and/or family history of tic disorders including Tourette’s syndrome is contraindicated. Patients with attention deficit hyperactivity disorder (ADHD), however, are at increased risk of tics regardless of stimulants use. After evaluating the most recent literature on the incidence of tic disorders in pediatric patients treated with stimulants for ADHD, it is reasonable to say that the incidence of tics and the severity of tics are not increased by the use of these medications. For patients with pre-existing tic disorders, the usual recommended dosing of stimulants should be used because supratherapeutic doses of this class of medications, specifically dextroamphetamine, have shown to exacerbate tic disorders.
Keywords: Amphetamine, attention deficit disorder with hyperactivity, methylphenidate, pediatrics, tics.
Current Pediatric Reviews
Title:Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents—What is the Verdict
Volume: 12 Issue: 3
Author(s): Tommi Cooke and Tsz-Yin So
Affiliation:
Keywords: Amphetamine, attention deficit disorder with hyperactivity, methylphenidate, pediatrics, tics.
Abstract: The United States Food and Drug Administration currently states that the use of stimulants in patients with tic disorders and/or family history of tic disorders including Tourette’s syndrome is contraindicated. Patients with attention deficit hyperactivity disorder (ADHD), however, are at increased risk of tics regardless of stimulants use. After evaluating the most recent literature on the incidence of tic disorders in pediatric patients treated with stimulants for ADHD, it is reasonable to say that the incidence of tics and the severity of tics are not increased by the use of these medications. For patients with pre-existing tic disorders, the usual recommended dosing of stimulants should be used because supratherapeutic doses of this class of medications, specifically dextroamphetamine, have shown to exacerbate tic disorders.
Export Options
About this article
Cite this article as:
Cooke Tommi and So Tsz-Yin, Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents—What is the Verdict, Current Pediatric Reviews 2016; 12 (3) . https://dx.doi.org/10.2174/1573396312666160728113443
DOI https://dx.doi.org/10.2174/1573396312666160728113443 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Analgesic Drug Use Associated with Statin Prescription – A Cross- Sectional Study in Primary Care Settings
Current Drug Safety Drp1 in Ischemic Neuronal Death: An Unusual Suspect
Current Medicinal Chemistry Somatostatin Involvement in Rheumatoid Arthritis
Current Rheumatology Reviews Inflammation, High Density Lipoprotein and Endothelium
Current Medicinal Chemistry Book Review: The New Handbook of Multisensory Processing. Barry E. Stein, ed. June 2012. The MIT Press. No. of pages 823. ISBN: 987-0-262-01712-1
Neuroscience and Biomedical Engineering (Discontinued) Music Therapy for Individuals with Dementia: Areas of Interventions and Research Perspectives
Current Alzheimer Research The Neuronal Histaminergic System in Cognition
Current Medicinal Chemistry - Central Nervous System Agents The Application of Proteomics in Neurology
Current Proteomics Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis
Current Pharmaceutical Biotechnology Editorial [Hot topic: Parkinsons Disease (Guest Editor: Jurgen Dinges)]
Current Topics in Medicinal Chemistry Commentary: What is Aging? Can it be Eliminated?
Current Aging Science Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Function and Frustration of Multi-Drug ABC Exporter Protein and Design of Model Proteins for Drug Delivery Using Protein Hydration Thermodynamics
Current Pharmaceutical Design The Water Channels, New Druggable Targets to Combat Cancer Cell Survival,Invasiveness and Metastasis
Current Drug Targets Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews Generation of Alzheimer’s Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor
Current Alzheimer Research Freezing of Gait in Parkinsonism and its Potential Drug Treatment
Current Neuropharmacology How Close are We in Achieving Safe, Affordable and Reversible Male Contraceptives?
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Exploitation of Endogenous Anti-Inflammatory Mechanisms:Old and New Leads
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry An Overview of Current Applications of Nanotechnology in Biomedical Research: A Patent Survey
Recent Patents on Nanomedicine